Assuring safety of fecal microbiota transplantation in the COVID-19 era: A single-center experience.

Tien-En ChangKuei-Chuan LeePei-Chang LeeYen-Po WangYi-Tsung LinHui-Chun HuangJiing-Chyuan LuoHsiang-Ling HoYi-Hsiang HuangMing-Chih Hounull null

Published in: JGH open : an open access journal of gastroenterology and hepatology (2023)

Our FMT center produced MDRO-free and COVID-19-free products before and during the COVID-19 outbreak in Taiwan. Our protocol was effective for ensuring the safety of FMT products.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
respiratory syndrome coronavirus
cell therapy